Be the first to like this
ISR’s report provides a thorough analysis of Forest Laboratories’ R&D pipeline, clinical trial activity, patents, FDA submissions, and includes profiles of Forest’s key products.
How You Can Use This Report:
Pharmaceutical Companies: Identify the clinical and commercial status of competing compounds and understand how these will affect the launch of similar products.
Service Providers: Learn Forest’s strategic direction and better understand their clinical development pipeline.
For the full report preview, with table of contents, additional sample pages, and ordering information, please visit our website: